Cargando…
Is HbA1c an ideal biomarker of well-controlled diabetes?
HbA1c is a biomarker with a central role in the diagnosis and follow-up of patients with diabetes, although not a perfect one. Common comorbidities encountered in patients with diabetes mellitus, such as renal insufficiency, high output states (iron deficiency anaemia, haemolytic anaemia, haemoglobi...
Autores principales: | Kaiafa, Georgia, Veneti, Stavroula, Polychronopoulos, George, Pilalas, Dimitrios, Daios, Stylianos, Kanellos, Ilias, Didangelos, Triantafyllos, Pagoni, Stamatina, Savopoulos, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016911/ https://www.ncbi.nlm.nih.gov/pubmed/32913038 http://dx.doi.org/10.1136/postgradmedj-2020-138756 |
Ejemplares similares
-
Circadian Pattern of Acute Myocardial Infarction and Atrial Fibrillation in a Mediterranean Country: A study in Diabetic Patients
por: Daios, Stylianos, et al.
Publicado: (2021) -
Diabetic Patient Adherence to Yearly Influenza Vaccination in Northern Greece
por: Pilalas, Dimitrios, et al.
Publicado: (2022) -
Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
por: Kaiafa, Georgia, et al.
Publicado: (2021) -
Coagulation Profile of COVID-19 Patients
por: Kaiafa, Georgia, et al.
Publicado: (2022) -
Dasatinib associated lymphadenopathy in a chronic myeloid leukemia patient: A case report
por: Pilalas, Dimitrios, et al.
Publicado: (2020)